Abstract
What might be the relation between clinical research and efficiency of medical care suppliers? Is the hypothesis of a positive relation consistent? Considering efficiency as the supplier’s ability to maximize the number of patients hospitalized in a mobility process among regions (i.e. mobility balance), this work aims at highlighting the existence of a positive externality of pharmaceutical clinical research on that kind of efficiency. In other words, an externality is able to affect the patients’ perception of good/bad quality of outputs supplied by the medical care industry, leading their mobility process. Taking Italy and the mobility of patients among regions into account, an Operational Research study will be performed in order to support this assumption. The goal of this work is to show an alternative way to increase the efficiency of medical care suppliers on the market of health care, that is to say, through their competitiveness on the market of human experimentation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
